readthroughSign in
CompanyLTGONasdaqThousand Oaks, CA

Latigo Biotherapeutics

Latigo Biotherapeutics is a clinical-stage company developing oral Nav1.8 ion channel inhibitors for pain.

SCHEDULE 13GNov 16Latest SEC filing
Nov 5Latest story